The potential of carboxytherapy in diseases of the urogenital system organs

Abstract

The potential of carboxytherapy in diseases of the urogenital system organs Recently carboxytherapy has been widely used for the treatment of many diseases, and it is associated with the high efficiency and low cost. Carboxytherapy as the method of treatment has been used for 70 years in the international medical practice and more than 50 years in aesthetic medicine. Aim. To substantiate the use of carboxytherapy as an innovative method of treatment for diseases of the urogenital system organs. Materials and methods. The analysis of scientific sources concerning the treatment of sexual dysfunction, erosion of the cervix, menopause, vulvovaginal atrophy, initial stages of the stress urinary incontinence, erectile dysfunction, and impotence was performed. Results. It has been determined that various variants of carboxytherapy can be used to obtain the antihypoxic, reparative-regenerative, spasmolitic, anti-inflammatory, analgesic and antioxidant effects in clinical practice as a result of the treatment. Patients with different pathologies of the urogenital system noted improvement in functioning of urogenital organs, release of pain, decrease in inflammation, mood stability, and good mental and physical performance. Therefore, the quality of life has been improved. Conclusions. Thus, СО 2 can be considered as a unique medicinal product, and carboxytherapy as an alternative treatment for many diseases.

The influence of different CO2 levels on hemodynamics: analytical review of literature

“…Також карбон (IV) оксид стимулює секрецію факторів росту, таких як фактор росту ендотелію судин, що призводить до утворення нових кровоносних судин (неоваскуляризації) та реваскуляризації. Вважають, що ендотеліальні клітини є автономним серцево-судинним ендокринним органом, який виконує ряд важливих функцій [28]. Вони є атикоагуляційним бар'єром між кровотоком і периферичними тканинами, регулюють кровотік, місцеве запалення і проліферацію судинних клітин [29].…”